Antidote, the tech startup formerly known as TrialReach, is gearing up to introduce a tool to automatically match patients’ EHRs to clinical trials.
AOBiome is running an iPhone-enabled Phase IIb trial of its bacterial treatment for acne with Novartis ($NVS)-backed virtual trial CRO Science 37.
With its measurable impact on patient survival, there’s no denying that immunotherapy is already causing momentum in ways that cancer is treated. Learn more…
Researchers have found 110 antiviral targets and several existing drugs that may hit them using gene-trap insertional mutagenesis and a computational framework…
Illumina has agreed to comarket Dovetail Genomics’ genome assembly service, an offering that leverages short-read sequencers to deliver long-range information.
Jun Wang’s iCarbonX has dipped into its Series A haul to buy Imagu Vision, an Israeli startup active in identifying and analyzing medical images.
Tute Genomics is crowdfunding a DNA sequencing scheme. The campaign is aiming to raise $100,000 by offering whole genome sequencing for between $999 and $1,499.
In a recent effort to characterize new targets of obesity, a collaborative effort has suggested a new mechanism that regulates obesity in the mouse’s brain.
A consortium of cancer centers has contracted HudsonAlpha Institute of Biotechnology to sequence 20,000 samples by 2019.
Medidata has signed up to provide its cloud platform and mobile health capabilities to Techfields Pharma.
Quertle has introduced a platform to enable researchers to unearth relevant information from journal articles, patents and other documents.